CAR-T Cell Targeted Delivery of Secreted Therapeutics for Solid Tumors
Time: 10 AM EST | November 24, 2025
CAR-T therapy has achieved remarkable success in hematologic malignancies but faces major hurdles in solid tumors due to their immunosuppressive microenvironment. Angiogenesis, driven by the VEGF pathway, plays a critical role in fueling tumor growth and suppressing immune responses.